ArticlemAbs

Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Ryo Hatano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.